Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin L Masters

Showing results (181-190 of 775) with videos related to

Pageof 78
Sort By:
Free Radical Biology & Medicine|November 30, 2007
Neurotoxicity from glutathione depletion is mediated by Cu-dependent p53 activationTai Du, Giuseppe D Ciccotosto, Greg A Cranston, et al.
Journal of Molecular Biology|July 21, 2006
Linker histone H1 binds to disease associated amyloid-like fibrilsJames A Duce, David P Smith, Rachel E Blake, et al.
The Australian and New Zealand Journal of Psychiatry|December 12, 2019
Cerebrospinal fluid neurofilament light chain is elevated in Niemann-Pick type C compared to psychiatric disorders and healthy controls and may be a marker of treatment responseDhamidhu Eratne, Samantha M Loi, Qiao-Xin Li, et al.
Communicable Diseases Intelligence (2018)|August 18, 2022
Creutzfeldt-Jakob disease surveillance in Australia: update to 31 December 2021Christiane Stehmann, Matteo Senesi, Shannon Sarros, et al.
Journal of Alzheimer'S Disease : JAD|August 14, 2022
Nationally Informed Recommendations on Approaching the Detection, Assessment, and Management of Mild Cognitive ImpairmentMichael Woodward, Henry Brodaty, Maree McCabe, et al.
Neurochemical Research|January 28, 2005
Brain beta-amyloid accumulation in transgenic mice expressing mutant superoxide dismutase 1Bradley J Turner, Qiao-Xin Li, Katrina M Laughton, et al.
Journal of Molecular Neuroscience : MN|August 13, 2016
A Conceptualization of the Utility of Subjective Cognitive Decline in Clinical Trials of Preclinical Alzheimer's DiseaseRachel F Buckley, Victor L Villemagne, Colin L Masters, et al.
Journal of Cell Science|April 23, 2009
Dominant roles of the polybasic proline motif and copper in the PrP23-89-mediated stress protection responseCathryn L Haigh, Simon C Drew, Martin P Boland, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 11, 2010
Addressing population aging and Alzheimer's disease through the Australian imaging biomarkers and lifestyle study: collaboration with the Alzheimer's Disease Neuroimaging InitiativeKathryn A Ellis, Christopher C Rowe, Victor L Villemagne, et al.
Neuroimage|July 16, 2023
Disease progression modelling of Alzheimer's disease using probabilistic principal components analysisMartin Saint-Jalmes, Victor Fedyashov, Daniel Beck, et al.
Pageof 78

Showing results (181-190 of 775) with videos related to

Sort By:
Pageof 78
Free Radical Biology & Medicine|November 30, 2007
Neurotoxicity from glutathione depletion is mediated by Cu-dependent p53 activationTai Du, Giuseppe D Ciccotosto, Greg A Cranston, et al.
Journal of Molecular Biology|July 21, 2006
Linker histone H1 binds to disease associated amyloid-like fibrilsJames A Duce, David P Smith, Rachel E Blake, et al.
The Australian and New Zealand Journal of Psychiatry|December 12, 2019
Cerebrospinal fluid neurofilament light chain is elevated in Niemann-Pick type C compared to psychiatric disorders and healthy controls and may be a marker of treatment responseDhamidhu Eratne, Samantha M Loi, Qiao-Xin Li, et al.
Communicable Diseases Intelligence (2018)|August 18, 2022
Creutzfeldt-Jakob disease surveillance in Australia: update to 31 December 2021Christiane Stehmann, Matteo Senesi, Shannon Sarros, et al.
Journal of Alzheimer'S Disease : JAD|August 14, 2022
Nationally Informed Recommendations on Approaching the Detection, Assessment, and Management of Mild Cognitive ImpairmentMichael Woodward, Henry Brodaty, Maree McCabe, et al.
Neurochemical Research|January 28, 2005
Brain beta-amyloid accumulation in transgenic mice expressing mutant superoxide dismutase 1Bradley J Turner, Qiao-Xin Li, Katrina M Laughton, et al.
Journal of Molecular Neuroscience : MN|August 13, 2016
A Conceptualization of the Utility of Subjective Cognitive Decline in Clinical Trials of Preclinical Alzheimer's DiseaseRachel F Buckley, Victor L Villemagne, Colin L Masters, et al.
Journal of Cell Science|April 23, 2009
Dominant roles of the polybasic proline motif and copper in the PrP23-89-mediated stress protection responseCathryn L Haigh, Simon C Drew, Martin P Boland, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 11, 2010
Addressing population aging and Alzheimer's disease through the Australian imaging biomarkers and lifestyle study: collaboration with the Alzheimer's Disease Neuroimaging InitiativeKathryn A Ellis, Christopher C Rowe, Victor L Villemagne, et al.
Neuroimage|July 16, 2023
Disease progression modelling of Alzheimer's disease using probabilistic principal components analysisMartin Saint-Jalmes, Victor Fedyashov, Daniel Beck, et al.
Pageof 78